Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapure PlasmaCap IG in Adults and Children With Primary Immune Deficiency Diseases
NCT03238079Phase 3Completed
- Sponsor
- Evolve Biologics
- Start
- Sep 2017
- Primary completion
- Aug 2020
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 2
01
Overview
A Phase 3 trial of polyvalent human immunoglobulin in primary immunodeficiency (PIDD), sponsored by Evolve Biologics. Started Sep 2017; status: completed.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
primary immunodeficiency (PIDD)
Beyond the preview
Go deeper on NCT03238079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03238079.